Australian antiviral drug development company Island Pharmaceuticals (ASX:ILA) has announced it has received commitments for a two-tranche placement to existing and new investors to raise approximately $3.5 million at 7 cents (A$0.07) per share.
Island Pharmaceuticals secures new funding to support key inflection points and pipeline build
October 6, 2024 Latest NewsAustralian Biotech
Latest Video
New Stories
-
PBS share of health spending on track to halve as Canberra prepares to negotiate with industry
October 26, 2026 - - Latest News -
UTI and contraception care comes to local pharmacies from February
October 26, 2026 - - Latest News -
Documents reveal net PBS spending set to remain on life support to the end of decade
October 26, 2026 - - Latest News -
Health's multi-million dollar rebuild of cost-recovery fees is happening out of view
October 26, 2026 - - Latest News -
There is an urgent need to reconsider the question of PBS sustainability
October 26, 2026 - - Latest News -
Australia leads the way as Moderna and MSD take personalised cancer vaccine into lung cancer
October 24, 2026 - - Latest News -
The private medicines boom has mostly passed vaccines by, for now
October 23, 2026 - - Latest News
